Second Autologous Hematopoietic Stem Cell Transplant as Salvage Therapy for Relapsed Multiple Myeloma: A Global Treatment Option for Eligible Patients

Acta Haematol. 2018;139(1):45-46. doi: 10.1159/000486272. Epub 2018 Jan 18.
No abstract available

Publication types

  • Editorial
  • Letter

MeSH terms

  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Hematopoietic Stem Cell Transplantation* / methods
  • Humans
  • Multiple Myeloma / pathology*
  • Multiple Myeloma / therapy*
  • Recurrence
  • Retreatment
  • Salvage Therapy
  • Treatment Outcome